» Authors » Monica Zanella

Monica Zanella

Explore the profile of Monica Zanella including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 63
Citations 326
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Marzano N, Caprara C, Reis T, Montin D, Pretto S, Rigato M, et al.
Genes (Basel) . 2025 Jan; 16(1). PMID: 39858586
: Autosomal Dominant Polycystic Kidney Disease (ADPKD) is mainly characterized by renal involvement with progressive bilateral development of renal cysts and volumetric increase in the kidneys, causing a loss of...
2.
Marcello M, Marturano D, Ronco C, Zanella M
Clin Kidney J . 2024 Sep; 17(9):sfae266. PMID: 39319306
Chronic kidney disease-associated pruritus (CKD-aP) is a common complication in dialysis patients which is not fully addressed by pharmacological and dialytic therapy. The objective was to review the literature on...
3.
Ferrari F, Milla P, Sartori M, Zanza C, Tesauro M, Longhitano Y, et al.
Clin Pharmacokinet . 2024 Aug; 63(8):1167-1176. PMID: 39102092
Background And Objective: Renal replacement therapy (RRT) plays a critical role in antimicrobial removal, particularly for low-molecular-weight drugs with low plasma protein binding, low distribution volume and hydrophilicity. Medium cut-off...
4.
Lorenzin A, De Cal M, Perin N, Morisi N, Brendolan A, Lentini P, et al.
Blood Purif . 2024 Jul; 53(10):773-780. PMID: 39068927
Introduction: Enkephalins, endogenous opioid peptides, are involved in the regulation of renal function. One derived molecule, proenkephalin A, also known as penKid, has been demonstrated to be a reliable biomarker...
5.
Morisi N, Virzi G, Ferrarini M, Alfano G, Zanella M, Ronco C, et al.
Genes (Basel) . 2024 May; 15(5). PMID: 38790182
Introduction: Cell-free nucleic acids (cf-NAs) represent a promising biomarker of various pathological and physiological conditions. Since its discovery in 1948, cf-NAs gained prognostic value in oncology, immunology, and other relevant...
6.
Virzi G, Morisi N, Marturano D, Milan Manani S, Tantillo I, Ronco C, et al.
Int J Mol Sci . 2024 Apr; 25(8). PMID: 38673869
Erythrocytes (RBCs) have a highly specialized and organized membrane structure and undergo programmed cell death, known as eryptosis. Our preliminary data show a significant increase in the eryptosis during peritoneal...
7.
Caprara C, Virzi G, Chieregato K, Marchionna N, Corradi V, Brendolan A, et al.
J Clin Med . 2024 Apr; 13(7). PMID: 38610912
: Patients with end-stage kidney disease (ESKD) have altered immunity. Patients on hemodialysis (HD) present a coexistence of immunodeficiency and activation of the immune system. We evaluated the immunophenotypic profile...
8.
Pavan P, Lorenzin A, Chiementin L, Perin N, De Cal M, Brendolan A, et al.
Blood Purif . 2024 Mar; 53(8):613-623. PMID: 38493768
Introduction: Per- and polyfluoroalkyl substances (PFAS) are known water pollutants leading to potential public health consequences. High blood levels of PFAS have been associated with several pathological conditions including testicular...
9.
Ramirez-Guerrero G, Ronco C, Lorenzin A, Brendolan A, Sgarabotto L, Zanella M, et al.
Heart Fail Rev . 2024 Jan; 29(3):615-630. PMID: 38289525
Acute decompensated heart failure and fluid overload are the most common causes of hospitalization in heart failure patients, and often, they contribute to disease progression. Initial treatment encompasses intravenous diuretics...
10.
Ramirez-Guerrero G, Reis T, Lorenzin A, Marcello M, De Cal M, Zanella M, et al.
Blood Purif . 2024 Jan; 53(6):500-504. PMID: 38281478
Introduction: Hemadsorption with new sorbent cartridges is an emerging extracorporeal blood purification technique. Flow distribution inside the sorbent is one of the main issues concerning the device's performance and optimal...